Home » Health News » Trial of ferric carboxymaltose in heart failure does not meet primary endpoint Trial of ferric carboxymaltose in heart failure does not meet primary endpoint 08/28/2023 Health News, Source: Read Full Article Previous: TB research shows a good diet can cut infections by nearly 50% Next: Get your blood pressure checked at mosques – what should your reading be?
